Percutaneous endoscopic gastrostomy in oropharyngeal cancer patients treated with intensity-modulated radiotherapy with concurrent chemotherapy
about
Patterns of failure in patients with head and neck carcinoma of unknown primary treated with radiation therapy.The effect of prophylactic percutaneous endoscopic gastrostomy (PEG) tube placement on swallowing and swallow-related outcomes in patients undergoing radiotherapy for head and neck cancer: a systematic review.Nephrotoxicity as a Dose-Limiting Factor in a High-Dose Cisplatin-Based Chemoradiotherapy Regimen for Head and Neck Carcinomas.Proton beam radiation therapy results in significantly reduced toxicity compared with intensity-modulated radiation therapy for head and neck tumors that require ipsilateral radiation.Proton Beam Reirradiation for Recurrent Head and Neck Cancer: Multi-institutional Report on Feasibility and Early Outcomes.Benefit of percutaneous endoscopic gastrostomy in patients undergoing definitive chemoradiotherapy for locally advanced nasopharyngeal carcinomaClinical review of physical activity and functional considerations in head and neck cancer patients.Systematic review of dose--volume correlates for structures related to late swallowing disturbances after radiotherapy for head and neck cancer.Clinical predictors for reactive tube feeding in patients with advanced oropharynx cancer receiving radiotherapy ± chemotherapy.Validation of an updated evidence-based protocol for proactive gastrostomy tube insertion in patients with head and neck cancer.New radiotherapy techniques do not reduce the need for nutrition intervention in patients with head and neck cancer.Critical Weight Loss in Patients With Oropharynx Cancer During Radiotherapy (± Chemotherapy).Complication and mortality rate after percutaneous endoscopic gastrostomy are low and indication-dependent.
P2860
Q33900702-97B01D00-FE2C-4BAB-9AAF-7BAD01267861Q35571111-E20D6E3F-E01A-48EF-8E6A-EFD4F8C8D602Q36638185-9A65319F-DA29-497A-A174-8C6983BB8845Q37165669-0B4EA13D-4C38-4130-9CA2-1D02F1F0ACB3Q37203612-8DCBDAAD-C6A2-4184-86BD-97E8757F365EQ37407412-50CB64C5-33E4-41A3-81BE-E877E4B36995Q38082429-6F0E9699-E16A-4C72-BA11-B98DD4E91404Q38083550-CFA605BF-8D8D-4860-BE5B-69CDC87CB8D8Q38658693-00EAE55E-17CC-4A9A-B9D3-1D5B9042AF5EQ40009126-EF365F1B-A231-45FD-97D5-9AACFD6F605BQ40608180-520AB7E8-E3C9-4B22-B059-1945C2DCE057Q47178948-85B88E6D-4530-471C-8861-263B5B5FBC4BQ50639607-8D7ECED4-665C-4002-BDBD-94CD5597D6F2
P2860
Percutaneous endoscopic gastrostomy in oropharyngeal cancer patients treated with intensity-modulated radiotherapy with concurrent chemotherapy
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 June 2012
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Percutaneous endoscopic gastro ...... y with concurrent chemotherapy
@en
Percutaneous endoscopic gastro ...... with concurrent chemotherapy.
@nl
type
label
Percutaneous endoscopic gastro ...... y with concurrent chemotherapy
@en
Percutaneous endoscopic gastro ...... with concurrent chemotherapy.
@nl
prefLabel
Percutaneous endoscopic gastro ...... y with concurrent chemotherapy
@en
Percutaneous endoscopic gastro ...... with concurrent chemotherapy.
@nl
P2093
P2860
P50
P356
P1433
P1476
Percutaneous endoscopic gastro ...... y with concurrent chemotherapy
@en
P2093
Dennis Kraus
Eric J Sherman
Jeremy Setton
Jonathan C Romanyshyn
Karen D Schupak
Nancy Y Lee
Suzanne L Wolden
P2860
P304
P356
10.1002/CNCR.27633
P407
P577
2012-06-15T00:00:00Z